Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Transparency notification received from Theodorus II SA

  • Read more about Transparency notification received from Theodorus II SA

Enrico Bastianelli to stand down as CEO of Bone Therapeutics

  • Read more about Enrico Bastianelli to stand down as CEO of Bone Therapeutics

Bone Therapeutics Notice of Q3 2016 Results - Results to be announced on 8 November 2016

  • Read more about Bone Therapeutics Notice of Q3 2016 Results - Results to be announced on 8 November 2016

Bone Therapeutics Business Update for Third Quarter 2016

  • Read more about Bone Therapeutics Business Update for Third Quarter 2016

Bone Therapeutics announces its financial calendar for 2017

  • Read more about Bone Therapeutics announces its financial calendar for 2017

Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region

  • Read more about Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region

Bone Therapeutics Provides Business Update for Q4 2016

  • Read more about Bone Therapeutics Provides Business Update for Q4 2016

Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017

  • Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017

Bone Therapeutics Notice of Full Year 2016 Results

  • Read more about Bone Therapeutics Notice of Full Year 2016 Results

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

  • Read more about Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions